CClinicalTrials.gg
Status unknownNCT01893619immunopropUpdated Jul 25, 2013

Observational Research on Use of Immunoprop Supplement in Chronic Fatigue Syndrome

An observational study in Chronic Fatigue Syndrome, sponsored by New York CFS Association. Status unknown at 1 site in United States. Open to participants aged 21 Years to 60 Years. Per ClinicalTrials.gov, last updated 2013-07-25.

Sponsored by New York CFS Association · Observational

The sponsor has not verified this record recently (last verified Jul 2013), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
21 Years to 60 Years
Sex
All
01

Study summary

Observational study regarding the use of supplements in chronic fatigue syndrome patients

Read the detailed description

Detailed questionnaire regarding the diagnosis of an onset of chronic fatigue syndrome and 100 patients. using Karnofsky scale before and after use of supplements patient scores are compared in a double blind trial.

02

Conditions studied

  • Chronic Fatigue Syndrome

Keywords

  • Chronic fatigue syndrome
  • Karnofsky score
  • supplements
03

In context

Fatigue Syndrome, Chronic

246 studies on the registry are indexed under Fatigue Syndrome, Chronic; 58 are open to participants now.

This study's planned enrollment of 100 is below the median of 150 across 71 observational studies indexed under Fatigue Syndrome, Chronic.

Browse Fatigue Syndrome, Chronic studies →

Lead sponsor

New York CFS Association is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Fukuda criteria and Canadian consensus criteria will be the diagnosis criteria for patient selection

Inclusion criteria

  • Fukuda criteria and Canadian consensus criteria will be the diagnosis criteria for patient selection

Exclusion criteria

Exclusion Criteria:

  • non inclusion in the above criteria
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Karnovsky score comparison

    Review of Karnofsky score over prior to diagnosis and subsequent to patients having taken supplements

    Time frame: Six months

07

Study locations

1 of 1 sites recruiting
  • Me/Cfs Center,860 Fifth Avenue
    New York, New York 10065, United States
    • derek enlander, MD · Contact · denlander@aol.com · 212-794-2000
    • derek enlander, md · Principal investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 25, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01893619
Lead sponsor
New York CFS Association
Responsible party
Sponsor
First posted
Jul 9, 2013
Start date
Jun 2013
Primary completion
Dec 2013 (estimated)
Completion
Dec 2013 (estimated)
Last update
Jul 25, 2013

Study contacts

DEREK enlander
principal investigator · CFIDS RESEARCH FOUNDATION

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion